Pro Medicus Limited (PME.AX)
Chart Events
Performance Outlook
| Previous Close | 72.37 |
| Open | 71.75 |
| Bid | 71.66 x 21400 |
| Ask | 71.69 x 12000 |
| Day's Range | 71.04 - 72.05 |
| 52 Week Range | 49.25 - 74.99 |
| Volume | |
| Avg. Volume | 147,656 |
| Market Cap | 7.559B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 123.57 |
| EPS (TTM) | 0.58 |
| Earnings Date | Aug 15, 2023 |
| Forward Dividend & Yield | 0.34 (0.47%) |
| Ex-Dividend Date | Sep 06, 2023 |
| 1y Target Est | 70.31 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PME.AX
Related Research
Simply Wall St.53% of Pro Medicus Limited (ASX:PME) is owned by insiders, and they've been buying recently
Key Insights Significant insider control over Pro Medicus implies vested interests in company growth The top 2...
- Simply Wall St.
Pro Medicus Full Year 2023 Earnings: Beats Expectations
Pro Medicus ( ASX:PME ) Full Year 2023 Results Key Financial Results Revenue: AU$127.3m (up 35% from FY 2022). Net...
PR NewswireVisage 7 Named Best in KLAS 2023
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the Visage® 7 Enterprise Imaging Platform ("Visage 7") has been ranked the #1 Universal Viewer (Imaging) in the 2023 Best in KLAS ® Software & Services Report by KLAS Research ("KLAS"). Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform, delivered entirely from the cloud or
